Biogen, Ionis will discontinue development of their ALS drug
(Reuters) - Biogen and Ionis Pharmaceuticals said on Thursday they will terminate the development of their treatment for amyo...
5h ago
Johnson & Johnson to acquire Proteologix for $850 million
(Reuters) - Johnson & Johnson on Thursday said it would acquire privately held Proteologix for $850 million in cash, with...
5h ago
Lilly's weekly insulin succeeds in late-stage studies
(Reuters) - Eli Lilly said on Thursday that its once-weekly insulin efsitora met the main goals in two late-stage trials eval...
6h ago
Thai cannabis groups urge government to rethink plan to re-criminalise marijuana
BANGKOK (Reuters) - Dozens of Thai cannabis advocates urged the government on Thursday to abandon its plans to re-list mariju...
7h ago
Roche shares gain on obesity drug results from early-stage trial
(Reuters) - Roche shares gained 4.7% at the market open on Thursday after an early-stage trial showed that the obesity drug c...
9h ago
AstraZeneca's investigational COVID drug meets primary goals in late-stage study
(Reuters) - AstraZeneca said on Thursday its investigational drug, sipavibart, met primary goals in preventing COVID-19 in im...
10h ago
Pfizer offers up to $250 million to settle thousands of Zantac cancer lawsuits, FT reports
(Reuters) - Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States ov...
13h ago
US FDA approves expanded use of Bristol's cancer cell therapy
(Reuters) -The U.S. health regulator said on Wednesday it has approved the expanded use of Bristol Myers Squibb's cancer cell...
20h ago
Canada says its commercial milk tests negative for bird flu
WASHINGTON (Reuters) - Canadian government officials said samples of commercially sold milk as of May 14 have shown "no ...
23h ago
UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down
(Reuters) - Britain's Pharmacy2U said on Wednesday it had cut the prices of weight-loss medication Wegovy and Mounjaro, becom...
May 15, 2024